Mogens Holst Nissen

Mogens Holst Nissen

Professor

Member of:

    ORCID: 0000-0001-7729-8667

    Publication year:
    All
    1 - 4 out of 4Page size: 10
    Sort by: 1st author
    1. Published

      Enhanced expression in vivo of HLA-ABC antigens and beta 2-microglobulin on human lymphoid cells induced by human interferon-alpha in patients with lung cancer. Enhanced expression of class I major histocompatibility antigens prior to treatment.

      Nissen, Mogens Holst, Plesner, T., Larsen, J. K., Olesen, B. K. & Ernst, P., 1985, In: Clinical and Experimental Immunology. 59, 2, p. 327-35 8 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    2. Published

      Creatine kinase BB and beta-2-microglobulin as markers of CNS metastases in patients with small-cell lung cancer.

      Pedersen, A. G., Bach, F. W., Nissen, Mogens Holst & Bach, F., 1985, In: Journal of Clinical Oncology. 3, 10, p. 1364-72 8 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    3. Published

      Phase I study of the cisplatin analogue 1,1-diamminomethylcyclohexane sulfatoplatinum (TNO-6) (NSC 311056).

      Sørensen, J. B., Groth, S., Hansen, S. W., Nissen, Mogens Holst, Rørth, M. & Hansen, H. H., 1985, In: Cancer Chemotherapy and Pharmacology. 15, 2, p. 97-100 3 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    4. Published

      Beta-2-microglobulin excretion: an indicator of long term nephrotoxicity during cis-platinum treatment?

      Sørensen, P. G., Nissen, Mogens Holst, Groth, S. & Rørth, M., 1985, In: Cancer Chemotherapy and Pharmacology. 14, 3, p. 247-9 2 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    ID: 7594